THIRD-PARTY PAYORS ACCOUNT FOR 51% Of Rx REVENUES -- NARD/LILLY DIGEST
Executive Summary
Third-party payors accounted for 51% of prescription department revenues in 1993, according to information from the first 528 pharmacies to report preliminary data for the 1994 NARD/Lilly Digest, Lilly Senior VP-Pharmacy Practice Management Service and Digest co-Editor D.C. Huffman, PhD, told the 96th Annual NARD Convention in Boston Oct. 17.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth